Ehave Accelerates Growth with LOI to Acquire India-Based Company

• Moksha Digital is the creator of the FDA-approved CuriePACS (Picture Archival and Communication System) and CurieRIS (Radiological Information System) solutions designed to meet the needs of radiologists, clinicians and surgeons.
• Moksha Digital creates software to help healthcare facilities improve quality and reduce costs by providing Image Archiving and Communication System (PACS), Radiological Information System (RIS), and Image Reporting System (RIS). histopathological information.

MIAMI and BANGALORE, India, August 24, 2021 (GLOBE NEWSWIRE) – Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapies providing patients with evidence-based therapeutic interventions, has announced today that it has signed a letter of intent to acquire 100% of Moksha Digital Software Pvt. Ltd., a provider of medical imaging software and the creator of the FDA has licensed the CuriePACS and CurieRIS solutions. CuriePACS and CurieRIS are used by radiologists, clinicians and surgeons in several hospitals and diagnostic centers around the world. The founders of Moksha Digital have worked for companies such as Sony, AOL Time Warner, SAP, Oracle, Citibank and Goldman Sachs around the world and collectively have decades of experience in imaging and software engineering offering proven expertise in imaging. medical. For more information on Moksha Digital, please visit http://mokshadigital.com.

Moksha Digital has offices in the Indian cities of Bangalore, Kolkata and Pune, as well as in the United States. It also works with a team of experienced and qualified partners and resellers in other regions. For structuring purposes, the assets of Moksha Digital will be acquired by Tennessine Software Trading LLC and Tennessine Software Trading LLC will be acquired by Ehave. Tennessine Software is looking to expand its business globally and has a business plan in place to increase sales of Moksha Digital’s software, as well as the Ehave dashboard.

CuriePACS and CurieRIS

CuriePACS is the flagship product of Moksha Digital and becomes the backbone for the integration of images and clinical data with the EHR as a means of bridging the gap between referring physicians and radiologists. CuriePACS uses state-of-the-art storage management software to store data in a lossless VNA format and receive images of all DICOM compliant and non-DICOM modalities. Images captured from the device are instantly available to multiple viewers, allowing physicians to consult radiologists for better diagnosis without wasting valuable patient time. CuriePACS is FDA approved and complies with international standards, such as DICOM, HL7 and HIPAA. It is platform independent and supports Windows, LINUX and Mac operating systems.

CurieRIS is state-of-the-art, highly customizable radiological information (RIS) software developed with cutting-edge next-generation technologies such as HTML5. CurieRIS is integrated with CuriePACS via HL7, an international healthcare standard, and has a wide variety of features for radiologists, physicians and administrators. Using a high level security system, CurieRIS provides a rich set of business, clinical and administrative functionality for management, physicians, radiologists and administrators. This makes it easier for everyone to connect to a single system, regardless of their location. In addition to the optimal planning of equipment, radiologists, technologists and patients, CurieRIS can track the entire radiological history of a patient, from admission to discharge with past and future appointments.

“CuriePACS and CurieRIS have been well accepted by physicians and hospitals and we are looking to further improve our software by harnessing the power of AI,” said Deepak Sharma, CEO of Moksha Digital. “We want to help patients by getting them a quick and accurate diagnosis, which in turn will improve patient outcomes. “

Benjamin Kaplan, CEO of Ehave, Inc., said, “The next phase of Ehave’s business plan is to monetize our Ehave dashboard. The Letter of Intent to Acquire Moksha Digital along with its sales force and marketing channels may accelerate our efforts as Dashboard complements Moksha’s existing product line. Mr. Kaplan continued, “Moksha Digital will also benefit tremendously, as the relationships Ehave has established in psychedelics and clinical trials will open up a whole new market for their medical imaging products and provide the opportunity to test future improvements based. on AI. We see the synergies between the two companies as a great victory for our shareholders, as well as for the shareholders of Moksha Digital. “

Ehave, Inc. will file a 6-K detailing the terms of the ACT on the SEC EDGAR website https://www.sec.gov/edgar/browse/?CIK=1653606&owner=exclude.

About Ehave, Inc.

Ehave, Inc. is a leader in digital therapy providing patients with evidence-based therapeutic interventions. Our primary goal is to improve standard therapeutic care to prevent or treat disorders or diseases of the brain through the use of digital therapies, independently or in conjunction with drugs, devices and other therapies to optimize outcomes. patient care and health outcomes. Our main product is the Ehave Telemetry Portal, which is a mental health computing platform that enables clinicians to make objective and intelligent decisions through data insight. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its key partners. This enables patients, healthcare providers and payers to treat a wide range of conditions through high-quality, safe and efficient data-driven engagement with smart and accessible tools. Additional information about Ehave is available on the Company‘s website at: www.ehave.com.

About Moksha Digital

Moksha Digital is a pioneering and leading solutions provider company committed to providing medical imaging solutions for the healthcare industry. Moksha Digital offers in-house CuriePACS (Picture Archival and Communication System) and RIS (Radiological Information System) solutions to meet the needs of radiologists, clinicians and surgeons. The founders of the company have worked for companies such as Sony, AOL Time Warner, SAP, Oracle, Citibank, and Goldman Sachs around the world and collectively have decades of imaging and software engineering experience that deliver proven expertise in medical imaging. Moksha Digital’s flagship product, CuriePACS, is FDA certified and provides proven PACS technology at lower prices than many multinational companies. Moksha Digital has offices in Bangalore, Kolkata, Pune, and the United States. We also work with a team of experienced and qualified partners and resellers in other regions. Additional information about Moksha Digital is available on the Company’s website at: http://mokshadigital.com.

Disclaimer regarding forward-looking statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. “” anticipates “,” plans “,” predicts “,” estimates “,” aims “,” believes “,” hopes “, “Potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of the Company, and cannot be predicted or quantified and, therefore, actual results may differ materially from those expressed or implied by these forward-looking statements: (i) the initiation, timing, progression and results of the Company’s research, manufacturing and development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacture, development, marketing and market acceptance of the Company’s products; (iv) lack of sufficient funding to finance product development and business operations; (v) competitive companies and technologies within the Company’s industry and the introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the extent of protection that the Company is able to establish and maintain for intellectual property rights covering its products and its ability to conduct business without infringing the intellectual property rights of others; (ix) potential non-compliance with applicable health information privacy and security laws and other federal and state privacy and security laws; and (x) the difficulty of predicting the actions of the US FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement, except as required by law. More detailed information about the Company and the risk factors that may affect the making of forward-looking statements are contained under the heading “Risk Factors” in the registration statement of Ehave, Inc. on Form F-1 filed with of the Securities and Exchange Commission. (SEC) September 24, 2015, as amended, available on the SEC’s website, http://www.sec.gov.

For Investor Relations, please contact:

Gabe Rodriguez
Telephone: (623) 261-9046
Email: [email protected]